These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11938937)

  • 1. [Study on the rifampicin polylactic acid microspheres for lung targeting].
    Zhang W; Jiang X; Zhu C; Hu J
    Yao Xue Xue Bao; 1998; 33(1):57-61. PubMed ID: 11938937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampicin polylactic acid microspheres for lung targeting.
    Zhang W; Jiang X; Hu J; Fu C
    J Microencapsul; 2000; 17(6):785-8. PubMed ID: 11063425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
    Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
    J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An experimental study on a slow-release complex with rifampicin-polylactic-co-glycolic acid-calcium 
phosphate cement].
    Wu J; Ding Z; Lei Q; Li M; Liang Y; Lu T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):946-54. PubMed ID: 27640793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin.
    Makino K; Nakajima T; Shikamura M; Ito F; Ando S; Kochi C; Inagawa H; Soma G; Terada H
    Colloids Surf B Biointerfaces; 2004 Jul; 36(1):35-42. PubMed ID: 15261021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and deposition of respirable PLGA microspheres in lung alveoli.
    Hirota K; Kawamoto T; Nakajima T; Makino K; Terada H
    Colloids Surf B Biointerfaces; 2013 May; 105():92-7. PubMed ID: 23384687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective delivery of rifampicin incorporated into poly(DL-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette-Guérin.
    Yoshida A; Matumoto M; Hshizume H; Oba Y; Tomishige T; Inagawa H; Kohchi C; Hino M; Ito F; Tomoda K; Nakajima T; Makino K; Terada H; Hori H; Soma G
    Microbes Infect; 2006 Aug; 8(9-10):2484-91. PubMed ID: 16879999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of lung-targeting, emodin-loaded polylactic acid microspheres and their properties.
    Chen X; Yang Z; Sun R; Mo Z; Jin G; Wei F; Hu J; Guan W; Zhong N
    Int J Mol Sci; 2014 Apr; 15(4):6241-51. PubMed ID: 24733070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on preparation process of artesunate polylactic acid microspheres].
    Pan XW; Wang W; Fang HY; Wang FG; Cai ZB
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4071-5. PubMed ID: 24791491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteogenetic capacity of cross-linked adjustable anti-tuberculosis drug sustained-release artificial composite].
    Xi YH; Xue MT; Ye XJ; Xu N; Qu JT; Liu XL; He HL
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1494-8. PubMed ID: 24029576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.
    Huo D; Deng S; Li L; Ji J
    Int J Pharm; 2005 Jan; 289(1-2):63-7. PubMed ID: 15652199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases.
    Freitas MN; Marchetti JM
    Int J Pharm; 2005 May; 295(1-2):201-11. PubMed ID: 15848005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatin microspheres of rifampicin cross-linked with sucrose using thermal gelation method for the treatment of tuberculosis.
    Samad A; Sultana Y; Khar RK; Chuttani K; Mishra AK
    J Microencapsul; 2009 Feb; 26(1):83-9. PubMed ID: 18608799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin-carrying poly(D,L-lactide) microspheres: loading and release.
    Denkbaş EB; Kaitian X; Tuncel A; Pişkin E
    J Biomater Sci Polym Ed; 1995; 6(9):815-25. PubMed ID: 7772568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of cucurbitacinBE polylactic acid nano-particles for targeting cervical lymph nodes].
    Yang K; Wen Y; Li L; Wang C; Hou S; Li C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):347-50. PubMed ID: 12539678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV; Couet W; Olivier JC
    Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow release formulations of inhaled rifampin.
    Coowanitwong I; Arya V; Kulvanich P; Hochhaus G
    AAPS J; 2008 Jun; 10(2):342-8. PubMed ID: 18584334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of in-vitro release characteristics of NSAID-loaded polylactic acid microspheres.
    Guiziou B; Armstrong DJ; Elliott PN; Ford JL; Rostron C
    J Microencapsul; 1996; 13(6):701-8. PubMed ID: 8933355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.